Skip to main content
. Author manuscript; available in PMC: 2020 Nov 23.
Published in final edited form as: Eur J Anaesthesiol. 2020 Nov;37(11):984–991. doi: 10.1097/EJA.0000000000001250

Table 1.

Characteristics of participants from the Study of Middle-Aged and elderly Twins according to APOE ε4 genotyping status, in totals and by surgery exposure group

Surgical procedure groups
Characteristics Totals Major surgery* Minor surgery Knee/hip
replacement
Other surgery No surgery
n (%)
Total genetic sample 2936(35) 549(36) 605(36) 46(27) 758(36) 978(33)
  APOE ε4 non-carriers 2013(24) 370(24) 412(24) 32(19) 526(25) 673(23)
  APOE ε4 carriers 923(11) 179(12) 193(11) 14(8) 232(11) 305(10)
Sample without genetic information 5567(65) 997(64) 1124(65) 125(73) 1334(64) 1987(67)
Female, n (% of all)
  APOE ε4 non-carriers 1148(25) 272(27) 219(26) 19(17) 312(27) 326(22)
  APOE ε4 carriers 495(11) 135(13) 92(11) 10(9) 125(11) 133(9)
Sample without genetic information 2917(64) 604(60) 526(63) 83(74) 707(62) 997(68)
Age, year
  APOE ε4 non-carriers 62.2(11.6) 61.8(11.6) 60.6(11) 69.3(10.1) 62(12.1) 63.1(11.5)
  APOE ε4 carriers 61.9(11.4) 62.7(11.3) 59.5(10) 77.5(3.5) 61.1(11.8) 63(11.6)
  Sample without genetic information 69.5(11) 70.8(10.7) 68(11.1) 74.1(7.7) 69.3(11.5) 69.4(10.8)
Cognitive score±
  APOE ε4 non-carriers −1.8(3.6) −1.7(3.4) −1.6(3.7) −3(3.5) −1.7(3.7) −2(3.4)
  APOE ε4 carriers −1.9(3.7) −1.8(3.9) −1.8(3.5) −3.7(2.8) −1.8(3.8) −2(3.5)
  Sample without genetic information −3.2(3.9) −3.7(4) −2.9(4.1) −3.4(3.9) −3.2(4) −3.1(3.8)
Slope in cognitive score±
  APOE ε4 non-carriers −0.78(2.7) −0.63(2.8) −0.78(2.7) −0.77(2.4) −0.64(2.6) −0.81(2.7)
  APOE ε4 carriers −0.78(2.8) −0.58(2.8) −0.79(3.2) −1.81(2.5) 0.33(2.5) −0.84(2.7)
*

Including cardiac, thoracic, laparotomy, central and peripheral vascular and fracture surgeries.

Median (IQR).

±

Mean (SD)